Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Evolus
EOLS
$551M
| $151K | ﹤0.01% |
+17,877
| New | +$162K |
|
|
QVCGA
2552
DELISTED
QVC Group Inc Series A
QVCGA
| $150K | ﹤0.01% |
3,083
+1,714
| +125% | +$154K |
|
|
ALLK
2553
DELISTED
Allakos
ALLK
| $150K | ﹤0.01% |
33,641
+15,641
| +87% | +$100K |
|
|
EBIX
2554
DELISTED
Ebix Inc
EBIX
| $150K | ﹤0.01% |
+11,340
| New | +$197K |
|
|
BIG
2555
DELISTED
Big Lots, Inc.
BIG
| $149K | ﹤0.01% |
+13,611
| New | +$206K |
|
2556
TETRA Technologies
TTI
$1.31B
| $148K | ﹤0.01% |
56,111
+27,675
| +97% | +$96.3K |
|
2557
Comtech Telecommunications
CMTL
$51.8M
| $148K | ﹤0.01% |
+11,899
| New | +$170K |
|
2558
Karyopharm Therapeutics
KPTI
$47.6M
| $148K | ﹤0.01% |
2,541
+1,728
| +213% | +$85.3K |
|
2559
Gran Tierra Energy
GTE
$337M
| $147K | ﹤0.01% |
16,510
+8,881
| +116% | +$76.8K |
|
2560
Alector
ALEC
$233M
| $147K | ﹤0.01% |
23,736
+13,176
| +125% | +$107K |
|
2561
Gevo
GEVO
$403M
| $147K | ﹤0.01% |
95,592
+55,164
| +136% | +$104K |
|
2562
ECARX Holdings
ECX
$409M
| $146K | ﹤0.01% |
+24,997
| New | +$146K |
|
|
ME
2563
DELISTED
23andMe Holding Co
ME
| $145K | ﹤0.01% |
3,188
+1,327
| +71% | +$64K |
|
2564
PLAYSTUDIOS Inc
MYPS
$81.1M
| $145K | ﹤0.01% |
39,250
+20,613
| +111% | +$83.5K |
|
2565
Recursion Pharmaceuticals
RXRX
$1.8B
| $143K | ﹤0.01% |
+21,384
| New | +$170K |
|
|
EQRX
2566
DELISTED
EQRx, Inc. Common Stock
EQRX
| $142K | ﹤0.01% |
73,479
+34,737
| +90% | +$79.1K |
|
2567
SES AI
SES
$206M
| $141K | ﹤0.01% |
47,880
+24,928
| +109% | +$78.6K |
|
2568
Bionano Genomics
BNGO
$13.7M
| $140K | ﹤0.01% |
211
+117
| +124% | +$104K |
|
2569
Solid Power
SLDP
$550M
| $139K | ﹤0.01% |
46,398
+24,367
| +111% | +$73.5K |
|
2570
Lindblad Expeditions
LIND
$2.15B
| $137K | ﹤0.01% |
+14,385
| New | +$145K |
|
|
FLIC
2571
DELISTED
First of Long Island Corp
FLIC
| $137K | ﹤0.01% |
+10,147
| New | +$170K |
|
|
TSVT
2572
DELISTED
2seventy bio
TSVT
| $136K | ﹤0.01% |
+13,354
| New | +$153K |
|
|
AAN
2573
DELISTED
The Aaron's Company Inc
AAN
| $135K | ﹤0.01% |
+13,932
| New | +$179K |
|
2574
Caribou Biosciences
CRBU
$168M
| $135K | ﹤0.01% |
25,333
+11,655
| +85% | +$72.6K |
|
|
CIO
2575
DELISTED
City Office REIT
CIO
| $134K | ﹤0.01% |
+19,417
| New | +$164K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.